These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17543780)

  • 1. Utilization of acoustic signatures to identify HeartMate XVE device end-of-life.
    Slaughter MS; Feldman CM; Sobieski MA; Silver MA; Martin MM; Kurien S; Coyle LA; Pederson B
    J Heart Lung Transplant; 2007 Jun; 26(6):579-83. PubMed ID: 17543780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
    Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
    J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved mechanical reliability of the HeartMate XVE left ventricular assist system.
    Pagani FD; Long JW; Dembitsky WP; Joyce LD; Miller LW
    Ann Thorac Surg; 2006 Oct; 82(4):1413-8. PubMed ID: 16996944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HeartMate VE LVAS design enhancements and its impact on device reliability.
    Dowling RD; Park SJ; Pagani FD; Tector AJ; Naka Y; Icenogle TB; Poirier VL; Frazier OH
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):958-63. PubMed ID: 15144995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exchange techniques for implantable ventricular assist devices.
    Gregoric ID
    ASAIO J; 2008; 54(1):14-9. PubMed ID: 18204310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system.
    Haft JW; Suzuki Y; Aaronson KD; Dyke DB; Wright S; Poirier VL; Pagani FD
    ASAIO J; 2007; 53(3):298-303. PubMed ID: 17515718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urgent pump exchange for stroke resulting from a distorted HeartMate XVE inflow conduit.
    Frazier OH; Forrester MD; Gemmato C; Gregoric ID
    J Heart Lung Transplant; 2007 Jun; 26(6):646-8. PubMed ID: 17543792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
    Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rupture of inlet graft of the HeartMate System: a case report.
    Schneider N; Joyce D; Southard R; Cross CA; Noon GP; Koerner MM; Loebe M
    J Heart Lung Transplant; 2006 Jan; 25(1):137-9. PubMed ID: 16399545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heartmate II axial-flow left ventricular assist system: management, clinical review and personal experience.
    Loforte A; Montalto A; Ranocchi F; Casali G; Luzi G; Monica PL; Sbaraglia F; Polizzi V; Distefano G; Musumeci F
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):765-71. PubMed ID: 19465866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Miller LW; Deng M; Naka Y; Mancini D
    Circ Heart Fail; 2009 Jan; 2(1):3-10. PubMed ID: 19808309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
    J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.